Ablynx sees clinical progress in 2010

Sunday 28 February 2010

Ablynx NV expects that its heavy-chain-only antibody technology will show clinical progress in 2010 from its own and partnered programmes. It also expects to report progress on new delivery technologies.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium